| Authors: |
Raji H; Institut Imagine Paris - Inserm U1163, 24 boulevard du Montparnasse, 75015, Paris, France.; Université Paris Cité, 85 boulevard Saint-Germain, 75006, Paris, France.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA., Bertoli F; Institut Imagine Paris - Inserm U1163, 24 boulevard du Montparnasse, 75015, Paris, France.; Université Paris Cité, 85 boulevard Saint-Germain, 75006, Paris, France.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA., Perez MJ; Institut Imagine Paris - Inserm U1163, 24 boulevard du Montparnasse, 75015, Paris, France.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA., Lam A; Institut Imagine Paris - Inserm U1163, 24 boulevard du Montparnasse, 75015, Paris, France., Volpicelli-Daley L; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.; Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, 1719 6th Ave South, Birmingham, AL, 35294, USA., Deleidi M; Institut Imagine Paris - Inserm U1163, 24 boulevard du Montparnasse, 75015, Paris, France. michela.deleidi@institutimagine.org.; Université Paris Cité, 85 boulevard Saint-Germain, 75006, Paris, France. michela.deleidi@institutimagine.org.; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA. michela.deleidi@institutimagine.org. |
